Suchbegriffe: PULMONARY HYPERTENSION, . Treffer: 350
Aktaa, S; Gale, CP; Brida, M; Giannakoulas, G; Kovacs, G; Adir, Y; Benza, RL; Böhm, M; Coats, A; D'Alto, M; Escribano-Subias, P; Ferrari, P; Galiè, N; Gibbs, JSR; Gin-Sing, W; Hoeper, MM; Humbert, M; Lang, IM; Maron, BA; Meszaros, G; Noordegraaf, AV; Price, LC; Pepke-Zaba, J; Rådegran, G; Reis, A; Sitbon, O; Torbicki, A; Ulrich, S; Rosenkranz, S; Delcroix, M
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology.
Eur J Heart Fail. 2023;
Doi: 10.1002/ejhf.2830
PubMed
FullText
FullText_MUG
Crnkovic, S; Rittchen, S; Jandl, K; Gindlhuber, J; Zabini, D; Mutgan, AC; Valzano, F; Boehm, PM; Hoetzenecker, K; Toller, W; Veith, C; Heinemann, A; Schermuly, RT; Olschewski, A; Marsh, LM; Kwapiszewska, G
Divergent Roles of Ephrin-B2/EphB4 Guidance System in Pulmonary Hypertension.
Hypertension. 2023; 80(2):e17-e28
Doi: 10.1161/HYPERTENSIONAHA.122.19479
Web of Science
PubMed
FullText
FullText_MUG
Foris, V; Kovacs, G; Avian, A; Bálint, Z; Douschan, P; Ghanim, B; Klepetko, W; Olschewski, A; Olschewski, H
Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker study.
Front Physiol. 2022; 13: 986295
Doi: 10.3389/fphys.2022.986295
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jandl, K; Radic, N; Zeder, K; Kovacs, G; Kwapiszewska, G
Pulmonary vascular fibrosis in pulmonary hypertension - The role of the extracellular matrix as a therapeutic target.
Pharmacol Ther. 2023; 247:108438
Doi: 10.1016/j.pharmthera.2023.108438
PubMed
FullText
FullText_MUG
Myronenko, O; Foris, V; Crnkovic, S; Olschewski, A; Rocha, S; Nicolls, MR; Olschewski, H
Endotyping COPD: hypoxia-inducible factor-2 as a molecular "switch" between the vascular and airway phenotypes?
Eur Respir Rev. 2023; 32(167):
Doi: 10.1183/16000617.0173-2022
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Richter, MJ; Fortuni, F; Alenezi, F; D'Alto, M; Badagliacca, R; Brunner, NW; van, Dijk, AP; Douschan, P; Gall, H; Ghio, S; Giudice, FL; Grünig, E; Haddad, F; Howard, L; Rajagopal, S; Stens, N; Stolfo, D; Thijssen, DHJ; Vizza, CD; Zamanian, RT; Zhong, L; Seeger, W; Ghofrani, HA; Tello, K
Imaging the right atrium in pulmonary hypertension: A systematic review and meta-analysis.
J Heart Lung Transplant. 2023; 42(4):433-446
Doi: 10.1016/j.healun.2022.11.007
Web of Science
PubMed
FullText
FullText_MUG
Schäfer, K; Tello, K; Pak, O; Richter, M; Gierhardt, M; Kwapiszewska, G; Veith, C; Fink, L; Gall, H; Hecker, M; Kojonazarov, B; Kraut, S; Lo, K; Wilhelm, J; Grimminger, F; Seeger, W; Schermuly, RT; Ghofrani, HA; Zahner, D; Gerstberger, R; Weissmann, N; Sydykov, A; Sommer, N
Decreased plasma levels of the brain-derived neurotrophic factor correlate with right heart congestion in pulmonary arterial hypertension.
ERJ Open Res. 2023; 9(2):
Doi: 10.1183/23120541.00230-2022
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Angleitner, P; Schlöglhofer, T; Wiedemann, D; Riebandt, J; Strassl, A; Mascherbauer, J; Kainz, M; Laufer, G; Zuckermann, A; Zimpfer, D
The HeartMate 6 and CardioMEMS for Fixed Pulmonary Hypertension.
ASAIO J. 2022; 68(5): e80-e83.
Doi: 10.1097/MAT.0000000000001480
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Bergler-Klein, J; Rainer, PP; Wallner, M; Zaruba, MM; Dörler, J; Böhmer, A; Buchacher, T; Frey, M; Adlbrecht, C; Bartsch, R; Gyöngyösi, M; Fürst, UM
Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology.
Wien Klin Wochenschr. 2022; 134(17-18):654-674
Doi: 10.1007/s00508-022-02031-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Dachs, TM; Duca, F; Rettl, R; Binder-Rodriguez, C; Dalos, D; Ligios, LC; Kammerlander, A; Grunig, E; Pretsch, I; Steringer-Mascherbauer, R; Ablasser, K; Wargenau, M; Mascherbauer, J; Lang, IM; Hengstenberg, C; Badr-Eslam, R; Kastner, J; Bonderman, D
Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial
EUR HEART J. 2022;
Doi: 10.1093/eurheartj/ehac389
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Douschan, P; Kovacs, G; Sassmann, T; Stadlbauer, V; Avian, A; Foris, V; Tatscher, E; Durchschein, F; Rainer, F; Spindelboeck, W; Wagner, M; Kniepeiss, D; Zollner, G; Bachmaier, G; Fickert, P; Olschewski, H; Stauber, RE
Pulmonary vascular disease and exercise hemodynamics in chronic liver disease.
Respir Med. 2022; 202:106987
Doi: 10.1016/j.rmed.2022.106987
Web of Science
PubMed
FullText
FullText_MUG
Hasan, H; Chouvarine, P; Diekmann, F; Diedrich, N; Koestenberger, M; Hansmann, G
Validation of the new paediatric pulmonary hypertension risk score by CMR and speckle tracking echocardiography.
Eur J Clin Invest. 2022; e13835
Doi: 10.1111/eci.13835
Web of Science
PubMed
FullText
FullText_MUG
Humbert, M; Kovacs, G; Hoeper, MM; Badagliacca, R; Berger, RMF; Brida, M; Carlsen, J; Coats, AJS; Escribano-Subias, P; Ferrari, P; Ferreira, DS; Ghofrani, HA; Giannakoulas, G; Kiely, DG; Mayer, E; Meszaros, G; Nagavci, B; Olsson, KM; Pepke-Zaba, J; Quint, JK; Rådegran, G; Simonneau, G; Sitbon, O; Tonia, T; Toshner, M; Vachiery, JL; Vonk, Noordegraaf, A; Delcroix, M; Rosenkranz, S, , ESC/ERS, Scientific, Document, Group
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Eur Heart J. 2022; 43(38):3618-3731
Doi: 10.1093/eurheartj/ehac237
Web of Science
PubMed
FullText
FullText_MUG
Jandl, K; Marsh, LM; Mutgan, AC; Crnkovic, S; Valzano, F; Zabini, D; Hoffmann, J; Foris, V; Gschwandtner, E; Klepetko, W; Prosch, H; Flick, H; Brcic, L; Kern, I; Heinemann, A; Olschewski, H; Kovacs, G; Kwapiszewska, G
Impairment of the NKT-STAT1-CXCL9 Axis Contributes to Vessel Fibrosis in Pulmonary Hypertension Caused by Lung Fibrosis.
Am J Respir Crit Care Med. 2022; 206(8):981-998
Doi: 10.1164/rccm.202201-0142OC
Web of Science
PubMed
FullText
FullText_MUG
Kovacs, G; Avian, A; Bachmaier, G; Troester, N; Tornyos, A; Douschan, P; Foris, V; Sassmann, T; Zeder, K; Lindenmann, J; Brcic, L; Fuchsjaeger, M; Agusti, A; Olschewski, H
Severe Pulmonary Hypertension in COPD: Impact on Survival and Diagnostic Approach.
Chest. 2022; 162(1):202-212
Doi: 10.1016/j.chest.2022.01.031
Web of Science
PubMed
FullText
FullText_MUG
Kovacs, G; Humbert, M; Herve, P; Avian, A; Galie, N; Lewis, G; Souza, R; Ulrich, S; Noordegraaf, AV; Andersen, M; Barbera, JA; Blanco, I; Condliffe, R; D'Alto, M; Egenlauf, B; Ewert, R; Gruenig, E; Heine, A; Herkenrath, S; Hsu, S; Kasperowicz, K; Mak, S; Maron, B; Mccabe, C; Oliveira, R; Rosenkranz, S; Savale, L; Saxer, S; Systrom, D; Tedford, R; Torbicki, A; Olschewski, H
Baseline characteristics of patients included into the ERS Clinical Research Collaboration: "Pulmonary Hemodynamics during Exercise - Research Network" (PEX-NET) registry
EUR RESPIR J. 2022; 60:
Doi: 10.1183/13993003.congress-2022.1211
Web of Science
FullText
FullText_MUG
Kräuter, C; Reiter, U; Kovacs, G; Reiter, C; Masana, M; Olschewski, H; Fuchsjäger, M; Stollberger, R; Reiter, G
Automated vortical blood flow-based estimation of mean pulmonary arterial pressure from 4D flow MRI.
Magn Reson Imaging. 2022; 88: 132-141.
Doi: 10.1016/j.mri.2022.02.007
Web of Science
PubMed
FullText
FullText_MUG
Kremer, N; Rako, Z; Douschan, P; Gall, H; Ghofrani, HA; Grimminger, F; Guth, S; Naeije, R; Rieth, A; Schulz, R; Seeger, W; Tedford, RJ; Vadász, I; Vanderpool, R; Wiedenroth, CB; Richter, MJ; Tello, K
Unmasking right ventricular-arterial uncoupling during fluid challenge in pulmonary hypertension.
J Heart Lung Transplant. 2022; 41(3):345-355
Doi: 10.1016/j.healun.2021.11.019
Web of Science
PubMed
FullText
FullText_MUG
Liang, L; Zhang, X; Ke, X; Song, Y; Brcic, L; Neal, JW; Xu, G; Chen, C
Diagnosis and treatment of pericardial mesothelioma by mediastinal mass resection: a case report.
Ann Transl Med. 2022; 10(24):1407
Doi: 10.21037/atm-22-4719
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Nikkho, SM; Richter, MJ; Shen, E; Abman, SH; Antoniou, K; Chung, J; Fernandes, P; Hassoun, P; Lazarus, HM; Olschewski, H; Piccari, L; Psotka, M; Saggar, R; Shlobin, OA; Stockbridge, N; Vitulo, P; Vizza, CD; Wort, SJ; Nathan, SD
Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension
PULM CIRC. 2022; 12(3): e12127
Doi: 10.1002/pul2.12127
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Reiter, G; Kovacs, G; Reiter, C; Schmidt, A; Fuchsjäger, M; Olschewski, H; Reiter, U
Left atrial acceleration factor as a magnetic resonance 4D flow measure of mean pulmonary artery wedge pressure in pulmonary hypertension.
Front Cardiovasc Med. 2022; 9:972142
Doi: 10.3389/fcvm.2022.972142
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Sallmon, H; Koestenberger, M; Avian, A; Reiterer, F; Schwaberger, B; Meinel, K; Cvirn, G; Kurath-Koller, S; Gamillscheg, A; Hansmann, G
Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertension.
J Perinatol. 2022; 42(6):781-787
Doi: 10.1038/s41372-022-01374-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Sassmann, T; Douschan, P; Foris, V; Tröster, N; Zeder, K; Brcic, L; Tornyos, A; Bachmaier, G; Fuchsjäger, M; Olschewski, H; Kovacs, G
Abnormal pulmonary hemodynamics during exercise is associated with exercise capacity in COPD.
Respir Res. 2022; 23(1): 331
Doi: 10.1186/s12931-022-02238-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Sassmann, T; Pienn, M; Kovacs, G; Douschan, P; Foris, V; John, N; Zeder, K; Zirlik, A; Olschewski, H
Recognition of early pulmonary structural changes with real-time high fidelity expiratory CO2 analysis
EUR RESPIR J. 2022; 60:
Doi: 10.1183/13993003.congress-2022.405
Web of Science
FullText
FullText_MUG
Schnoegl, D; Hochgerner, M; Gotthardt, D; Marsh, LM
Fra-2 Is a Dominant Negative Regulator of Natural Killer Cell Development.
FRONT IMMUNOL. 2022; 13: 909270
Doi: 10.3389/fimmu.2022.909270
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schweintzger, S; Kurath-Koller, S; Burmas, A; Grangl, G; Fandl, A; Noessler, N; Avian, A; Gamillscheg, A; Chouvarine, P; Hansmann, G; Koestenberger, M
Normal Echocardiographic Reference Values of the Right Ventricular to Left Ventricular Endsystolic Diameter Ratio and the Left Ventricular Endsystolic Eccentricity Index in Healthy Children and in Children With Pulmonary Hypertension.
Front Cardiovasc Med. 2022; 9: 950765
Doi: 10.3389/fcvm.2022.950765
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Veith, C; Vartürk-Özcan, I; Wujak, M; Hadzic, S; Wu, CY; Knoepp, F; Kraut, S; Petrovic, A; Gredic, M; Pak, O; Brosien, M; Heimbrodt, M; Wilhelm, J; Weisel, FC; Malkmus, K; Schäfer, K; Gall, H; Tello, K; Kosanovic, D; Sydykov, A; Sarybaev, A; Günther, A; Brandes, RP; Seeger, W; Grimminger, F; Ghofrani, HA; Schermuly, RT; Kwapiszewska, G; Sommer, N; Weissmann, N
SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension.
Circulation. 2022; 145(12):916-933
Doi: 10.1161/CIRCULATIONAHA.121.057001
Web of Science
PubMed
FullText
FullText_MUG
Zeder, K; Olschewski, H; Kovacs, G
Updated definition of exercise pulmonary hypertension.
Breathe (Sheff). 2022; 18(4):220232
Doi: 10.1183/20734735.0232-2022
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ferrara, F; Gargani, L; Contaldi, C; Agoston, G; Argiento, P; Armstrong, WF; Bandera, F; Cademartiri, F; Citro, R; Cittadini, A; Cocchia, R; D'Alto, M; D'Andrea, A; Douschan, P; Ghio, S; Grunig, E; Guazzi, M; Guida, S; Kasprzak, JD; Kolias, TJ; Limongelli, G; Marra, AM; Mazzola, M; Mauro, C; Moreo, A; Pieri, F; Pratali, L; Pugliese, NR; Raciti, M; Ranieri, B; Rudski, L; Saggar, R; Salzano, A; Serra, W; Stanziola, AA; Vannan, M; Voilliot, D; Vriz, O; Wierzbowska-Drabik, K; Naeije, R; Bossone, E
A multicentric quality-control study of exercise Doppler echocardiography of the right heart and the pulmonary circulation. The RIGHT Heart International NETwork (RIGHT-NET)
CARDIOVASC ULTRASOUN. 2021; 19(1): 9
Doi: 10.1186/s12947-021-00238-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fließer, E; Birnhuber, A; Marsh, LM; Gschwandtner, E; Klepetko, W; Olschewski, H; Kwapiszewska, G
Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD.
J Pathol Clin Res. 2021; 7(5):446-458
Doi: 10.1002/cjp2.224
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Foris, V; Mutgan, CA; Borenich, A; Kovacs, G; Douschan, P; Sassmannn, T; Zeder, K; Olschewski, A; Kwapiszewska, G; Olschewski, H
Dehydroepiandrosterone and GDF-15 for follow-up of patients with pulmonary arterial hypertension
EUR RESPIR J. ERS International Congress 2021 abstracts. 2021; 58: -ERS International Congress; SEP 5-8, 2021; Virtuell.
Doi: 10.1183/13993003.congress-2021.OA144
[Poster]
Web of Science
FullText
FullText_MUG
Gredic, M; Blanco, I; Kovacs, G; Helyes, Z; Ferdinandy, P; Olschewski, H; Barberà, JA; Weissmann, N
Pulmonary hypertension in chronic obstructive pulmonary disease.
Br J Pharmacol. 2021; 178(1):132-151
Doi: 10.1111/bph.14979
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Grünig, E; MacKenzie, A; Peacock, AJ; Eichstaedt, CA; Benjamin, N; Nechwatal, R; Ulrich, S; Saxer, S; Bussotti, M; Sommaruga, M; Ghio, S; Gumbiene, L; Palevičiūtė, E; Jurevičienė, E; Cittadini, A; Stanziola, AA; Marra, AM; Kovacs, G; Olschewski, H; Barberà, JA; Blanco, I; Spruit, MA; Franssen, FME; Vonk, Noordegraaf, A; Reis, A; Santos, M; Viamonte, SG; Demeyer, H; Delcroix, M; Bossone, E; Johnson, M
Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial.
Eur Heart J. 2021; 42(23): 2284-2295.
Doi: 10.1093/eurheartj/ehaa696
Web of Science
PubMed
FullText
FullText_MUG
Guntur, D; Olschewski, H; Enyedi, P; Csáki, R; Olschewski, A; Nagaraj, C
Revisiting the Large-Conductance Calcium-Activated Potassium (BKCa) Channels in the Pulmonary Circulation.
Biomolecules. 2021; 11(11):
Doi: 10.3390/biom11111629
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hansmann, G; Christou, H; Koestenberger, M; Sallmon, H
Off-label use of PAH-targeted medications approved for adults and their financial coverage by health insurances are vital for children with pulmonary hypertension.
EUR J CLIN INVEST. 2021; 51(8): e13571
Doi: 10.1111/eci.13571
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hansmann, G; Sallmon, H; Roehr, CC; Kourembanas, S; Austin, ED; Koestenberger, M, , European, Pediatric, Pulmonary, Vascular, Disease, Network, (EPPVDN)
Pulmonary hypertension in bronchopulmonary dysplasia.
Pediatr Res. 2021; 89(3):446-455
Doi: 10.1038/s41390-020-0993-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hoeper, MM; Al-Hiti, H; Benza, RL; Chang, SA; Corris, PA; Gibbs, JSR; Grünig, E; Jansa, P; Klinger, JR; Langleben, D; McLaughlin, VV; Meyer, GMB; Ota-Arakaki, J; Peacock, AJ; Pulido, T; Rosenkranz, S; Vizza, CD; Vonk-Noordegraaf, A; White, RJ; Chang, M; Kleinjung, F; Meier, C; Paraschin, K; Ghofrani, HA; Simonneau, G; REPLACE investigators
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
Lancet Respir Med. 2021;
Doi: 10.1016/S2213-2600(20)30532-4
Web of Science
PubMed
FullText
FullText_MUG
Kovacs, G; Olschewski, H
The definition of pulmonary hypertension: history, practical implications and current controversies
BREATHE. 2021; 17(3): 210076
Doi: 10.1183/20734735.0076-2021
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Lammers, AE; Apitz, C; Michel-Behnke, I; Koestenberger, M
A guide to echocardiographic assessment in children and adolescents with pulmonary hypertension
CARDIOVASC DIAGN THE. 2021;
Doi: 10.21037/cdt-21-119
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Le, Ribeuz, H; To, L; Ghigna, MR; Martin, C; Nagaraj, C; Dreano, E; Rucker-Martin, C; Girerd, B; Bouligand, J; Pechoux, C; Lambert, M; Boet, A; Issard, J; Mercier, O; Hoetzenecker, K; Manoury, B; Becq, F; Burgel, PR; Cottart, CH; Olschewski, A; Sermet-Gaudelus, I; Perros, F; Humbert, M; Montani, D; Antigny, F
Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension.
Eur Respir J. 2021; 58(5):
Doi: 10.1183/13993003.00653-2020
Web of Science
PubMed
FullText
FullText_MUG
Maron, BA; Abman, SH; Elliott, CG; Frantz, RP; Hopper, RK; Horn, EM; Nicolls, MR; Shlobin, OA; Shah, SJ; Kovacs, G; Olschewski, H; Rosenzweig, EB
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.
Am J Respir Crit Care Med. 2021; 203(12): 1472-1487.
Doi: 10.1164/rccm.202012-4317SO
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Meinel, K; Koestenberger, M; Sallmon, H; Hansmann, G; Pieles, GE
Echocardiography for the Assessment of Pulmonary Hypertension and Congenital Heart Disease in the Young.
Diagnostics (Basel). 2020; 11(1):
Doi: 10.3390/diagnostics11010049
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Olschewski, H
The Challenge to Decide between Pulmonary Hypertension Due to Chronic Lung Disease and PAH with Chronic Lung Disease.
DIAGNOSTICS. 2021; 11(2): 311
Doi: 10.3390/diagnostics11020311
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Reiter, U; Kovacs, G; Reiter, C; Kräuter, C; Nizhnikava, V; Fuchsjäger, M; Olschewski, H; Reiter, G
MR 4D flow-based mean pulmonary arterial pressure tracking in pulmonary hypertension.
Eur Radiol. 2021; 31(4):1883-1893
Doi: 10.1007/s00330-020-07287-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Richter, MJ; Zedler, D; Berliner, D; Douschan, P; Gall, H; Ghofrani, HA; Kimmig, L; Kremer, N; Olsson, KM; da Rocha, BB; Rosenkranz, S; Seeger, W; Yogeswaran, A; Rako, Z; Tello, K
Clinical Relevance of Right Atrial Functional Response to Treatment in Pulmonary Arterial Hypertension
FRONT CARDIOVASC MED. 2021; 8: 775039
Doi: 10.3389/fcvm.2021.775039
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schlein, J; Riebandt, J; Laufer, G; Zimpfer, D
Reversal of pulmonary hypertension in paediatric patients with restrictive cardiomyopathy.
Interact Cardiovasc Thorac Surg. 2021; 33(5): 834-836.
Doi: 10.1093/icvts/ivab163
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Urganci, E; Wiedemann, D; Riebandt, J; Schaefer, AK; Hornykewycz, S; Laufer, G; Zimpfer, D
Implanting the HeartMate 6 (total artificial heart).
Multimed Man Cardiothorac Surg. 2021; 2021:
Doi: 10.1510/mmcts.2021.012
(- Case Report)
PubMed
FullText
FullText_MUG
Altekruse, A; Kovacs, G; Sassmann, T; Foris, V; Avian, A; Stadlbauer, V; Stauber, R; Olschewski, H; Douschan, P
Pulmonary exercise hemodynamics in patients with liver cirrhosis - a stress echocardiography study.
EUR RESPIR J. 2020; 56:
Doi: 10.1183/13993003.congress-2020.1513
[Poster]
Web of Science
FullText
FullText_MUG
Douschan, P; Foris, V; Avian, A; Sassmann, T; Olschewski, H; Kovacs, G
MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension.
EUR RESPIR J. 2020; 56:
Doi: 10.1183/13993003.congress-2020.1508
[Poster]
Web of Science
FullText
FullText_MUG
Fan, Y; Gu, X; Zhang, J; Sinn, K; Klepetko, W; Wu, N; Foris, V; Solymosi, P; Kwapiszewska, G; Kuebler, WM
TWIST1 Drives Smooth Muscle Cell Proliferation in Pulmonary Hypertension via Loss of GATA-6 and BMPR2.
Am J Respir Crit Care Med. 2020; 202(9):1283-1296
Doi: 10.1164/rccm.201909-1884OC
Web of Science
PubMed
FullText
FullText_MUG
Weitere 50 Treffer anzeigen